Lido Advisors LLC Increases Stock Position in Kenvue Inc. $KVUE

Lido Advisors LLC increased its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 13.0% during the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 260,711 shares of the company’s stock after purchasing an additional 29,986 shares during the period. Lido Advisors LLC’s holdings in Kenvue were worth $4,495,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the business. Oak Thistle LLC purchased a new stake in shares of Kenvue during the fourth quarter valued at about $1,563,000. Mirae Asset Global Investments Co. Ltd. grew its position in shares of Kenvue by 25.8% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 410,874 shares of the company’s stock worth $7,088,000 after buying an additional 84,219 shares during the last quarter. Calamos Advisors LLC grew its position in shares of Kenvue by 24.1% in the 1st quarter. Calamos Advisors LLC now owns 3,351,000 shares of the company’s stock worth $57,771,000 after buying an additional 651,000 shares during the last quarter. Cohen Capital Management Inc. bought a new position in shares of Kenvue during the 4th quarter worth approximately $2,448,000. Finally, Nomura Asset Management Co. Ltd. raised its stake in shares of Kenvue by 21.5% during the 4th quarter. Nomura Asset Management Co. Ltd. now owns 3,491,548 shares of the company’s stock worth $60,229,000 after acquiring an additional 618,720 shares in the last quarter. 97.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the stock. Citigroup decreased their target price on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a research report on Wednesday, April 15th. Zacks Research lowered shares of Kenvue from a “strong-buy” rating to a “hold” rating in a report on Tuesday, July 7th. Barclays upped their price target on Kenvue from $18.00 to $19.00 and gave the stock an “equal weight” rating in a research report on Tuesday. Weiss Ratings upgraded Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, June 15th. Finally, UBS Group upped their target price on Kenvue from $18.00 to $20.00 and gave the company a “neutral” rating in a research report on Thursday, July 16th. Three research analysts have rated the stock with a Buy rating and thirteen have issued a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $19.58.

Insider Transactions at Kenvue

In other Kenvue news, General Counsel Matthew Orlando sold 38,491 shares of the company’s stock in a transaction on Friday, May 8th. The shares were sold at an average price of $17.66, for a total value of $679,751.06. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.59% of the stock is owned by corporate insiders.

Kenvue Stock Up 1.9%

Kenvue stock opened at $19.25 on Friday. The business’s 50-day simple moving average is $18.38 and its two-hundred day simple moving average is $17.92. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.70 and a current ratio of 0.98. The company has a market cap of $36.97 billion, a PE ratio of 22.65, a PEG ratio of 1.43 and a beta of 0.47. Kenvue Inc. has a fifty-two week low of $14.02 and a fifty-two week high of $22.87.

Kenvue (NYSE:KVUE) last announced its quarterly earnings data on Thursday, May 7th. The company reported $0.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.05. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The firm had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $3.84 billion. During the same period last year, the business posted $0.24 earnings per share. The company’s revenue for the quarter was up 4.5% compared to the same quarter last year. Equities analysts anticipate that Kenvue Inc. will post 1.16 EPS for the current year.

Kenvue Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 27th. Stockholders of record on Wednesday, May 13th were paid a $0.2075 dividend. The ex-dividend date was Wednesday, May 13th. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.3%. Kenvue’s dividend payout ratio is presently 97.65%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.